{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:47:04Z","timestamp":1792673224797,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10840-021-01031-w","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T03:30:51Z","timestamp":1625196651000},"page":"487-494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A prospective multi-site registry of real-world experience of catheter ablation for treatment of symptomatic paroxysmal and persistent atrial fibrillation (Real-AF): design and objectives"],"prefix":"10.1007","volume":"62","author":[{"given":"Allyson L.","family":"Varley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Kreidieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigham E.","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Whitmire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Thorington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrinivas","family":"Hebsur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipin K.","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Zishiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Gidney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Metzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Ro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Westby G.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Costea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Magnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumil","family":"Oza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Rajendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Silverstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Zei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"issue":"9","key":"1031_CR1","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","volume":"120","author":"L Staerk","year":"2017","unstructured":"Staerk L, et al. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120(9):1501\u201317.","journal-title":"Circ Res"},{"issue":"23","key":"1031_CR2","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1161\/CIRCULATIONAHA.110.946806","volume":"122","author":"F Ouyang","year":"2010","unstructured":"Ouyang F, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation. 2010;122(23):2368\u201377.","journal-title":"Circulation"},{"key":"1031_CR3","doi-asserted-by":"crossref","unstructured":"European Heart Rhythm A, et al. HRS\/EHRA\/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2007;4(6):816\u201361.","DOI":"10.1016\/j.hrthm.2007.04.005"},{"issue":"2","key":"1031_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.hrthm.2017.10.010","volume":"15","author":"S Conti","year":"2018","unstructured":"Conti S, et al. Contact force sensing for ablation of persistent atrial fibrillation: a randomized, multicenter trial. Heart Rhythm. 2018;15(2):201\u20138.","journal-title":"Heart Rhythm"},{"issue":"3","key":"1031_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10840-015-0056-7","volume":"44","author":"K Nakamura","year":"2015","unstructured":"Nakamura K, et al. Randomized comparison of contact force-guided versus conventional circumferential pulmonary vein isolation of atrial fibrillation: prevalence, characteristics, and predictors of electrical reconnections and clinical outcomes. J Interv Card Electrophysiol. 2015;44(3):235\u201345.","journal-title":"J Interv Card Electrophysiol"},{"issue":"10","key":"1031_CR6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1161\/CIRCULATIONAHA.114.014092","volume":"132","author":"VY Reddy","year":"2015","unstructured":"Reddy VY, et al. Randomized, controlled trial of the safety and effectiveness of a contact force-sensing irrigated catheter for ablation of paroxysmal atrial fibrillation: results of the TactiCath contact force ablation catheter study for atrial fibrillation (TOCCASTAR) study. Circulation. 2015;132(10):907\u201315.","journal-title":"Circulation"},{"issue":"7","key":"1031_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jacc.2014.04.072","volume":"64","author":"A Natale","year":"2014","unstructured":"Natale A, et al. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Coll Cardiol. 2014;64(7):647\u201356.","journal-title":"J Am Coll Cardiol"},{"key":"1031_CR8","doi-asserted-by":"crossref","unstructured":"Chinitz LA, et al. Safety and efficiency of porous-tip contact-force catheter for drug-refractory symptomatic paroxysmal atrial fibrillation ablation: results from the SMART SF trial. Europace. 2018;20(FI_3):f392-f400.","DOI":"10.1093\/europace\/eux264"},{"issue":"4","key":"1031_CR9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.hrthm.2007.11.007","volume":"5","author":"TJ Bunch","year":"2008","unstructured":"Bunch TJ, Day JD. Novel ablative approach for atrial fibrillation to decrease risk of esophageal injury. Heart Rhythm. 2008;5(4):624\u20137.","journal-title":"Heart Rhythm"},{"key":"1031_CR10","doi-asserted-by":"crossref","unstructured":"Qiu J, et al. Update on high-power short-duration ablation for pulmonary vein isolation. J Cardiovasc Electrophysiol. 2020.","DOI":"10.1111\/jce.14649"},{"issue":"12","key":"1031_CR11","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1111\/jce.14219","volume":"30","author":"S Chen","year":"2019","unstructured":"Chen S, et al. Ablation index-guided 50 W ablation for pulmonary vein isolation in patients with atrial fibrillation: procedural data, lesion analysis, and initial results from the FAFA AI High Power Study. J Cardiovasc Electrophysiol. 2019;30(12):2724\u201331.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"1031_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jacep.2017.06.023","volume":"4","author":"P Taghji","year":"2018","unstructured":"Taghji P, et al. Evaluation of a strategy aiming to enclose the pulmonary veins with contiguous and optimized radiofrequency lesions in paroxysmal atrial fibrillation: a pilot study. JACC Clin Electrophysiol. 2018;4(1):99\u2013108.","journal-title":"JACC Clin Electrophysiol"},{"issue":"11","key":"1031_CR13","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/europace\/euaa157","volume":"22","author":"M Duytschaever","year":"2020","unstructured":"Duytschaever M, et al. Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions: the multicentre VISTAX trial. Europace. 2020;22(11):1645\u201352.","journal-title":"Europace"},{"key":"1031_CR14","doi-asserted-by":"crossref","unstructured":"Ganesan AN, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2):e004549.","DOI":"10.1161\/JAHA.112.004549"},{"issue":"10","key":"1031_CR15","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.amjcard.2016.08.014","volume":"118","author":"L Yang","year":"2016","unstructured":"Yang L, et al. Meta-analysis of zero or near-zero fluoroscopy use during ablation of cardiac arrhythmias. Am J Cardiol. 2016;118(10):1511\u20138.","journal-title":"Am J Cardiol"},{"issue":"9","key":"1031_CR16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/j.1540-8159.2012.03480.x","volume":"35","author":"AL Waldo","year":"2012","unstructured":"Waldo AL, et al. Safety of the open-irrigated ablation catheter for radiofrequency ablation: safety analysis from six clinical studies. Pacing Clin Electrophysiol. 2012;35(9):1081\u20139.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"6","key":"1031_CR17","doi-asserted-by":"publisher","first-page":"e023775","DOI":"10.1136\/bmjopen-2018-023775","volume":"9","author":"L Macle","year":"2019","unstructured":"Macle L, et al. Atrial fibrillation ablation with a spring sensor-irrigated contact force-sensing catheter compared with other ablation catheters: systematic literature review and meta-analysis. BMJ Open. 2019;9(6):e023775.","journal-title":"BMJ Open"},{"issue":"11","key":"1031_CR18","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.19102\/icrm.2020.111105","volume":"11","author":"PC Zei","year":"2020","unstructured":"Zei PC, et al. Safety and efficacy of minimal- versus zero-fluoroscopy radiofrequency catheter ablation for atrial fibrillation: a multicenter, prospective study. J Innov Card Rhythm Manag. 2020;11(11):4281\u201391.","journal-title":"J Innov Card Rhythm Manag"},{"issue":"3","key":"1031_CR19","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/jce.14367","volume":"31","author":"M Goya","year":"2020","unstructured":"Goya M, et al. The use of intracardiac echocardiography catheters in endocardial ablation of cardiac arrhythmia: Meta-analysis of efficiency, effectiveness, and safety outcomes. J Cardiovasc Electrophysiol. 2020;31(3):664\u201373.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"1031_CR20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1161\/CIRCULATIONAHA.119.042706","volume":"141","author":"SM Al-Khatib","year":"2020","unstructured":"Al-Khatib SM, et al. Research needs and priorities for catheter ablation of atrial fibrillation: a report from a National Heart, Lung, and Blood Institute Virtual Workshop. Circulation. 2020;141(6):482\u201392.","journal-title":"Circulation"},{"issue":"1","key":"1031_CR21","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.hrthm.2018.09.021","volume":"16","author":"H Calkins","year":"2019","unstructured":"Calkins H, et al. Harmonized outcome measures for use in atrial fibrillation patient registries and clinical practice: Endorsed by the Heart Rhythm Society Board of Trustees. Heart Rhythm. 2019;16(1):e3\u201316.","journal-title":"Heart Rhythm"},{"issue":"17","key":"1031_CR22","first-page":"1303","volume":"38","author":"E Arbelo","year":"2017","unstructured":"Arbelo E, et al. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J. 2017;38(17):1303\u201316.","journal-title":"Eur Heart J"},{"issue":"5","key":"1031_CR23","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1161\/CIRCOUTCOMES.114.001263","volume":"7","author":"WR Lewis","year":"2014","unstructured":"Lewis WR, et al. Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2014;7(5):770\u20137.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"9","key":"1031_CR24","doi-asserted-by":"publisher","first-page":"e007944","DOI":"10.1161\/CIRCEP.119.007944","volume":"13","author":"Z Loring","year":"2020","unstructured":"Loring Z, et al. Procedural patterns and safety of atrial fibrillation ablation: findings from get with the guidelines-atrial fibrillation. Circ Arrhythm Electrophysiol. 2020;13(9):e007944.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"1031_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche NF, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417\u201327.","journal-title":"N Engl J Med"},{"issue":"13","key":"1031_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.0693","volume":"321","author":"DL Packer","year":"2019","unstructured":"Packer DL, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321(13):1261\u201374.","journal-title":"JAMA"},{"issue":"8","key":"1031_CR27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jacep.2020.04.023","volume":"6","author":"HD Yavin","year":"2020","unstructured":"Yavin HD, et al. Impact of high-power short-duration radiofrequency ablation on long-term lesion durability for atrial fibrillation ablation. JACC Clin Electrophysiol. 2020;6(8):973\u201385.","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"1031_CR28","first-page":"775","volume":"19","author":"M Das","year":"2017","unstructured":"Das M, et al. Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. Europace. 2017;19(5):775\u201383.","journal-title":"Europace"},{"key":"1031_CR29","doi-asserted-by":"crossref","unstructured":"Romero J, et al. Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Europace. 2018;20(10):1612\u20131620.","DOI":"10.1093\/europace\/euy133"},{"issue":"17","key":"1031_CR30","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","volume":"376","author":"H Calkins","year":"2017","unstructured":"Calkins H, et al. Uninterrupted Dabigatran versus Warfarin for ablation in atrial fibrillation. N Engl J Med. 2017;376(17):1627\u201336.","journal-title":"N Engl J Med"},{"key":"1031_CR31","doi-asserted-by":"crossref","unstructured":"Cappato R, et al. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation. Eur Heart J. 2015;36(28):1805\u201311.","DOI":"10.1093\/eurheartj\/ehv177"},{"issue":"19","key":"1031_CR32","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.113.003862","volume":"128","author":"A Deshmukh","year":"2013","unstructured":"Deshmukh A, et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation. 2013;128(19):2104\u201312.","journal-title":"Circulation"},{"issue":"10","key":"1031_CR33","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.hrthm.2020.04.033","volume":"17","author":"JP Piccini Sr","year":"2020","unstructured":"Piccini JP Sr, et al. Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective. Heart Rhythm. 2020;17(10):1804\u201332.","journal-title":"Heart Rhythm"},{"issue":"12","key":"1031_CR34","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1093\/europace\/eux378","volume":"20","author":"P Sommer","year":"2018","unstructured":"Sommer P, et al. Safety profile of near-zero fluoroscopy atrial fibrillation ablation with non-fluoroscopic catheter visualization: experience from 1000 consecutive procedures. Europace. 2018;20(12):1952\u20138.","journal-title":"Europace"},{"issue":"1","key":"1031_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/pace.13841","volume":"43","author":"T Baykaner","year":"2020","unstructured":"Baykaner T, et al. Safety and efficacy of zero fluoroscopy transseptal puncture with different approaches. Pacing Clin Electrophysiol. 2020;43(1):12\u20138.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"4","key":"1031_CR36","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.19102\/icrm.2020.110406","volume":"11","author":"M Razminia","year":"2020","unstructured":"Razminia M, Zei P. Fluoroless catheter ablation of cardiac arrhythmias: change is inevitable. J Innov Card Rhythm Manag. 2020;11(4):4076\u20138.","journal-title":"J Innov Card Rhythm Manag"},{"issue":"7","key":"1031_CR37","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1108\/JHOM-06-2016-0110","volume":"30","author":"J Ovretveit","year":"2016","unstructured":"Ovretveit J, Nelson E, James B. Building a learning health system using clinical registers: a non-technical introduction. J Health Organ Manag. 2016;30(7):1105\u201318.","journal-title":"J Health Organ Manag"},{"key":"1031_CR38","doi-asserted-by":"crossref","unstructured":"Rajendra A, et al. Prospective implementation of a same-day discharge protocol for catheter ablation of paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2020.","DOI":"10.1007\/s10840-020-00914-8"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-021-01031-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-021-01031-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-021-01031-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:23:09Z","timestamp":1744190589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-021-01031-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1031"],"URL":"https:\/\/doi.org\/10.1007\/s10840-021-01031-w","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"assertion":[{"value":"1 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The registry protocol and activities have been approved by WCG IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Brigham Godfrey reports honoraria and consulting from Biosense Webster. Benjamin D\u2019Souza reports honoraria and consulting from Biosense Webster, Abbott, and Stereotaxis. Steven Kang reports honoraria and consulting from Biosense Webster and Boston Scientific. Brett Gidney reports Consulting and Speaking for Biosense Webster, Nuvera, Boston Scientific, Atricure, Abbott, Janssen, and Siemens. Tariq Salam reports consulting from Biosense Webster. Mark D. Metzl reports honoraria and consulting from Abbot, Biosense Webster, and Medtronic. Alexandru Costea reports honoraria and consulting from Biosense Webster and BIOTRONIK. Saumil Oza reports honoraria and consulting from Biosense Webster. Gustavo Morales reports research support, consulting, and honoraria from Biosense Webster. Anil Rajendra reports honoraria and consulting from Biosense Webster, Philips, and Acutus Medical. Joshua Silverstein reports honoraria and consulting from Biosense Webster and Medtronic. Paul C. Zei reports research support and consulting from Biosense Webster; consulting and honoraria from Abbot; research support and consulting from Varian, Boehringer Ingelheim (expert witness); and consulting from Affera. Jose Osorio serves as a consultant for and has received honoraria and research grants from Biosense Webster and Boston Scientific. The rest of the authors have no conflicts of interest or disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The views expressed in this article are those of the\u00a0authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the\u00a0United States government.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}